Dr. Amaria on Genetically Modified TILs in Melanoma
1 Visninger
• 07/03/23
0
0
Indlejre
administrator
Abonnenter
Rodabe N. Amaria, MD, Department of Melanoma Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, discusses genetically modified tumor infiltrating lymphocytes (TILs) for patients with advanced melanoma.
Vis mere
Facebook kommentarer
SORT BY-
Topkommentarer
-
Seneste kommentarer